A Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19

NCT04363372 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Recruitment Issues

Conditions

COVID-19

Interventions

DRUG: MRx-4DP0004
DRUG: Placebo

Sponsor

4D pharma plc